Delivery Order SPE2DB20D1100-SPE2DB25FE1BX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,617.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Montelukast Sodium 10 mg, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger prime contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,366.73 to AmerisourceBergen Drug Corp for the supply of Montelukast Sodium 5 mg chewable tablets (90-count packaging). The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be delivered from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Montelukast Sodium 5 mg Chewable Tablets. The contract has a ceiling value of $1,278.43 and a period of performance through March 20, 2024. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999 and a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Montelukast Sodium 10 mg tablets. The award, valued at $1,171.19, is a firm fixed-price delivery order contract with an ultimate completion date of August 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Montelukast 5mg tablets (90-unit quantity) with a ceiling value of $3,561.84. This delivery order was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,242 to Amerisourcebergen Drug Corporation to supply 1,000 tablets of montelukast sodium 10 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 11-12, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for a common asthma medication supports...
- The Defense Logistics Agency awarded a $9,780 delivery order to Amerisourcebergen Drug Corporation for the supply of 90 boxes of Montelukast sodium 10 mg tablets. The contract has a firm fixed price and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania between September 8-11, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this delivery order for a common asthma medication supports the Agency's mission to provide essential...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,557,734,379 units of Montelukast Sodium 10 mg tablets. The award has a ceiling value of $4,756.49 and was issued on July 7, 2022, with a completion date of July 8, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 1,000 bottles of Montelukast Sodium 10 mg tablets, a medication used to treat asthma and allergies. The total ceiling value of the contract is $1,727.93, and it is a firm fixed-price delivery order with an ultimate completion date of August 8, 2024. This order is not associated with a set-aside program....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,064 units of Montelukast 5mg tablets to the U.S. government. The $1,259.26 Firm Fixed Price contract was awarded on July 3, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of July 3, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1BXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Montelukast Sodium 10 mg tablets in a quantity of 500 units, with a firm fixed price ceiling value of $1,081.72. The contract was competitively awarded without a set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a continuation of the company's role as a critical pharmaceutical supplier to federal military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Montelukast, a bronchodilator commonly used to treat asthma and allergic rhinitis, is among the diverse therapeutic medications supplied through this strategic partnership with the Defense Logistics Agency, which manages the medical supply chain for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/25/25 |